CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 260 enrolled
Drug / intervention
BBN +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03331276
NCT03331276N/ACompleted
CompareCT.gov

Growth and Safety Study of an Infant Formula for Healthy Term Infants

Building Block Nutritionals, LLC·interventional·Posted Nov 6, 2017·Updated Oct 19, 2020

In Brief

A clinical study evaluating BBN and Brand for Infant Development. Completed, enrolled 260 participants across 6 sites.

Detailed Summary

A goal of infant formula development is to mimic human milk (HM) both in nutrient composition as well as physiologic outcomes. investigators have developed an infant formula for term infants that more closely resembles the composition of human milk. The purpose of this study is to demonstrate that this formulation meets nutritional requirements and supports age appropriate growth of healthy term infants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfant Development
CountriesUnited States
CollaboratorsPaidion Research, Inc.

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 6, 2017
Enrollment StartSep 18, 2017
Primary CompletionJan 7, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.7 years ago

Interventions

BBNother

BBN to be feed as the sole source of nutrition for 16 weeks to healthy term infants for 16 weeks.

Brandother

Brand to be feed as the sole source of nutrition for 16 weeks to healthy term infants for 16 weeks.